Osteoarthritis: Causes, Symptoms & Treatment
Osteoarthritis, also known as degenerative joint disease, occurs when cartilage between the joints wears down over time, which can cause pain and joint stiffness.
Chronicle of the Horse
New FDA-Approved Injectable Osteoarthritis Drug Available Soon
The U.S. Food and Drug Administration has recently approved a new drug for the treatment of equine joint dysfunction due to non-infectious synovitis or osteoarthritis.
Biopharm GmbH Enters into Co-Research Agreement with Merck
Biopharm GmbH , Heidelberg, announced today that they have signed an agreement with Merck to cooperate with Merck Serono , the biopharmaceutical division of Merck in their research activities directed toward the molecular engineering of a biologic compound for the treatment of osteoarthritis.
Woman, 56, needs knee replacement after being over-prescribed steroids
The Nigerian national was ministered 10 steroid injections in a matter of months, when not more than 3-4 are recommended in a year for one joint http://www.mid-day.com/news/2013/nov/201113-mumbai-woman-56-needs-knee-replacement-after-being-over-prescribed-steroids.htm The Nigerian national was ministered 10 steroid injections in a matter of months, ... (more)
What you need to know about osteoarthritis in pets
Although signs of osteoarthritis are not always present, things to watch for include reluctance to climb stairs, difficulty jumping, stiffness after exercise, limping, difficulty rising, difficulty with positioning to eliminate, loss of appetite and changes in behavior.
US pre-open: Stocks called to start on a mixed footing
The main US equity averages are being called to start the day on a mixed footing, albeit with just the slightest of falls for the S&P 500 and Nasdaq-100.
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
AstraZeneca will retain ex-U.S. rights to VIMOVO. "The acquisition of VIMOVO is a major step forward in our strategy to leverage our business model and maximize our commercial infrastructure and we expect it to create significant value for our shareholders," stated Timothy P. Walbert, chairman, president and chief executive officer of Horizon.
Asbury Park Press
New Robotic Arm Technology Offers Greater Accuracy for Joint Replacent
Breakthrough Robotic Arm Technology at Monmouth Medical Center Offers New Level of Accuracy and Reproducibility for Partial Knee and Total Hip Replacement Monmouth Medical Center is the first hospital in central and southern New Jersey to introduce robotic-assisted partial knee resurfacing and total hip replacement procedures.